Purchase Order 36C25925P0925

Award Date 7/17/25
Potential Completion Date 9/17/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Novocure's Optune Plus Transducers, a medical device system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers. The contract has a ceiling value of $16,582.91 and a period of performance ending on December 24, 2025....
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $49,748.73 contract is for the delivery of Novocure's Optune system, a medical device that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is part of Novocure's larger $28.85 million Federal...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is not set aside and is part of a larger $28.85...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the rental of Optune Plus Transducers, which utilize Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order. It is not...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $16,582.91 contract is for the provision of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract is not set aside and is awarded...
This is a $49,748.73 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for Novocure's Optune Transducers, a cancer therapy system using its proprietary Tumor Treating Fields (TTFields) technology. The contract is not set aside and is issued under Novocure's existing 5-year, $28.85 million Federal Supply Schedule (FSS)...

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of transducers, with an ultimate completion date of September 17, 2025 and a ceiling value of $49,748.73.

Novocure is the prime contractor and will directly provide its Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is part of Novocure's larger $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined procurement vehicle for the VA to obtain Novocure's innovative cancer treatment technologies. The contract does not have a set-aside designation, likely due to the specialized nature of Novocure's medical device offerings.

Generated 7/21/25, 4:46 PM